Literature DB >> 20933119

Acceptability of contraception for men: a review.

Anna Glasier1.   

Abstract

Methods of contraception for use by men include condoms, withdrawal and vasectomy. Prevalence of use of a method and continuation rates are indirect measures of acceptability. Worldwide, none of these "male methods" accounts for more than 7% of contraceptive use although uptake varies considerably between countries. Acceptability can be assessed directly by asking about intended (hypothetical) use and assessing satisfaction during/after use. Since they have been around for a very long time, there are very few data of this nature on condoms (as contraceptives rather than for prevention of infection), withdrawal or vasectomy. There are direct data on the acceptability of hormonal methods for men but from relatively small clinical trials which undoubtedly do not represent the real world. Surveys undertaken among the male general public demonstrate that, whatever the setting, at least 25% of men - and in most countries substantially more - would consider using hormonal contraception. Although probably an overestimate of the number of potential users when such a method becomes available, it would appear that hormonal contraceptives for men may have an important place on the contraceptive menu. Despite commonly expressed views to the contrary, most women would trust their male partner to use a hormonal method.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20933119     DOI: 10.1016/j.contraception.2010.03.016

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  22 in total

1.  [Vasectomy : Current information].

Authors:  Thomas Kreutzig-Langenfeld; Ekaterina Lellig; Peter Hinz; Fabian Zilg
Journal:  Urologe A       Date:  2021-03-18       Impact factor: 0.639

2.  What About Methods for Men? A Qualitative Analysis of Attitudes Toward Male Contraception in Burkina Faso and Uganda.

Authors:  Alice F Cartwright; Anna Lawton; Aurélie Brunie; Rebecca L Callahan
Journal:  Int Perspect Sex Reprod Health       Date:  2020-09-25

Review 3.  Continuing the search for a hormonal male contraceptive.

Authors:  Fiona Yuen; Brian T Nguyen; Ronald S Swerdloff; Christina Wang
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2020-02-19       Impact factor: 5.237

4.  "I'd Rather Use a Refuse Bag:" A Qualitative Exploration of a South African Community's Perceptions of Government-Provided Condoms and Participant-Preferred Solutions.

Authors:  Cho-Hee Shrader; Kenisha Peters Jefferson; Mariano Kanamori; Roger Rochat; Aaron Siegler
Journal:  Arch Sex Behav       Date:  2020-05-04

Review 5.  Update on Novel Hormonal and Nonhormonal Male Contraceptive Development.

Authors:  Jill E Long; Min S Lee; Diana L Blithe
Journal:  J Clin Endocrinol Metab       Date:  2021-05-13       Impact factor: 5.958

6.  Comparison of the single dose pharmacokinetics, pharmacodynamics, and safety of two novel oral formulations of dimethandrolone undecanoate (DMAU): a potential oral, male contraceptive.

Authors:  R Ayoub; S T Page; R S Swerdloff; P Y Liu; J K Amory; A Leung; L Hull; D Blithe; A Christy; J H Chao; W J Bremner; C Wang
Journal:  Andrology       Date:  2016-12-01       Impact factor: 4.456

Review 7.  Male hormonal contraception: hope and promise.

Authors:  Katarzyna Piotrowska; Christina Wang; Ronald S Swerdloff; Peter Y Liu
Journal:  Lancet Diabetes Endocrinol       Date:  2016-02-23       Impact factor: 44.867

8.  "I'm not going to be a guinea pig:" Medical mistrust as a barrier to male contraception for Black American men in Los Angeles, CA.

Authors:  Brian T Nguyen; Anthony L Brown; Felica Jones; Loretta Jones; Mellissa Withers; Katharine M Ciesielski; Jennifer M Franks; Christina Wang
Journal:  Contraception       Date:  2021-06-09       Impact factor: 3.051

Review 9.  Emerging approaches to male contraception.

Authors:  Arthi Thirumalai; John K Amory
Journal:  Fertil Steril       Date:  2021-04-27       Impact factor: 7.490

10.  Safety and Pharmacokinetics of Single-Dose Novel Oral Androgen 11β-Methyl-19-Nortestosterone-17β-Dodecylcarbonate in Men.

Authors:  Sherry Wu; Fiona Yuen; Ronald S Swerdloff; Youngju Pak; Arthi Thirumalai; Peter Y Liu; John K Amory; Feng Bai; Laura Hull; Diana L Blithe; Bradley D Anawalt; Toufan Parman; Kyuri Kim; Min S Lee; William J Bremner; Stephanie T Page; Christina Wang
Journal:  J Clin Endocrinol Metab       Date:  2019-03-01       Impact factor: 6.134

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.